Table 1 Baseline characteristics of 234 HIV-1 infected naïve patients, Dar es Salaam, 2010
Characteristics | Females (N = 164) | Males (N = 70) | P Value |
|---|---|---|---|
Categorical Variables | N (%) | N (%) | |
Primary level education | 156 (95.1) | 59 (84.3) | 0.005 |
Above 100 US Dollar monthly income | 57 (34.8) | 43 (61.4) | 0.0002 |
Having relative to remind to take medication | 133 (81.1) | 59 (84.3) | 0.95 |
Alcohol Intake | 33 (20.1) | 18 (25.7) | 0.4 |
Use of traditional medicine | 97 (59.2) | 45 (65.2) | 0.5 |
History of Intravenous Drug abuse | 8 (4.9) | 7 (10) | 0.2 |
Knowledge on ARV use and side effects | 10 (6.9) | 14 (20) | 0.005 |
HIV testing due to Chronic illness | 105 (64) | 55 (78.6) | 0.04 |
Starting treatment within one year of HIV diagnosis | 130 (79.3) | 55 (78.6) | 0.96 |
Presence of 2 or more opportunistic infections | 75 (45.7) | 37 (52.9) | 0.3 |
WHO Staging at initiation of therapy | |||
Stage I | 16 (9.8) | 5 (7.1) | 0.6 |
Stage II | 49 (29.9) | 16 (22.9) | 0.3 |
Stage III | 82 (50.0) | 34 (48.6) | 0.8 |
Stage IV | 17 (10.4) | 15 (21.4) | 0.04 |
CD4 < 100 cells/μl at ART initiation | 50 (33.3)* | 31 (47.0)* | 0.05 |
Continuous variables | Median (IQR) | Median (IQR) | P Value |
Age (Years) | 35 (30.5-43.5) | 37 (33.5-42.0) | 0.38 |
CD4 (cells/μl) at ART initiation | 149 (6-148; 75-218) | 102 (3-221; 47-184) | 0.02 |
Continuous Variables | Mean (SD) | Mean (SD) | P Value |
BMI at initiation of therapy | 22 (5) | 20 (4) | 0.002 |
Log10 Viral Load (RNA copies/ml) at initiation of therapy | 5.1 (1.3) | 5.5 (1.1) | 0.05 |